Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 8,740.00
+180.00 (2.10%)
At close: Mar 6, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 113.15 billion as of March 9, 2026. Its market cap has decreased by -1.91% in one year.
Market Cap
113.15B
Enterprise Value
104.51B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8,740.00
Market Cap Chart
Since July 27, 2023, Pharos iBio's market cap has increased from 112.78B to 113.15B, an increase of 0.32%. That is a compound annual growth rate of 0.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 113.15B | -6.92% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyung Dong Pharmaceutical | 148.18B |
| DongKoo Bio & Pharma | 145.49B |
| KOREA PHARMA | 138.95B |
| PHARMARESEARCH BIO | 131.48B |
| HYUNDAI BIOLAND | 124.95B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 115.12B |
| Samik Pharmaceutical Company LTD. | 110.45B |
| H.PIO | 98.44B |